Visão selecionada em Inglês
Descritor em português: | Anistreplase | ||||||
Descritor em inglês: | Anistreplase | ||||||
Descritor em espanhol: |
Anistreplasa
| ||||||
Descritor em francês: | Anistreplase | ||||||
Termo(s) alternativo(s): |
APSAC Anisoylated Plasminogen-Streptokinase Activator Complex BRL 26921 BRL-26921 BRL26921 Eminase Iminase |
||||||
Código(s) hierárquico(s): |
D08.811.277.656.300.760.635.075 D08.811.277.656.300.775.075 D08.811.277.656.959.350.635.075 D12.776.124.125.662.537.075 |
||||||
Identificador Único RDF: | https://id.nlm.nih.gov/mesh/D016255 | ||||||
Nota de escopo: | An acylated inactive complex of streptokinase and human lysine-plasminogen. After injection, the acyl group is slowly hydrolyzed, producing an activator that converts plasminogen to plasmin, thereby initiating fibrinolysis. Its half-life is about 90 minutes compared to 5 minutes for TPA; (TISSUE PLASMINOGEN ACTIVATOR); 16 minutes for UROKINASE-TYPE PLASMINOGEN ACTIVATOR and 23 minutes for STREPTOKINASE. If treatment is initiated within 3 hours of onset of symptoms for acute myocardial infarction, the drug preserves myocardial tissue and left ventricular function and increases coronary artery patency. Bleeding complications are similar to other thrombolytic agents. |
||||||
Qualificadores permitidos: |
AD administration & dosage AE adverse effects AI antagonists & inhibitors AN analysis BI biosynthesis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis DE drug effects DF deficiency EC economics GE genetics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PH physiology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UL ultrastructure UR urine |
||||||
Ação Farmacológica: |
Fibrinolíticos |
||||||
Número de registro: | 81669-57-0 | ||||||
Nome CAS Tipo 1: | Anistreplase | ||||||
Indexação Anterior: |
Fibrinolytic Agents (1966-1990) Plasminogen (1966-1990) Streptokinase (1966-1990) |
||||||
Nota MeSH pública: | 91 |
||||||
Nota histórica: | 91 |
||||||
Identificador DeCS: | 28860 | ||||||
ID do descritor: | D016255 | ||||||
Documentos indexados na Biblioteca Virtual em Saúde (BVS): | Clique aqui para acessar os documentos da BVS | ||||||
Data de estabelecimento: | 01/01/1991 | ||||||
Data de entrada: | 07/05/1990 | ||||||
Data de revisão: | 01/07/2016 |
-
-
CHEMICALS AND DRUGS
Enzymes and Coenzymes [D08]Enzymes and Coenzymes -
CHEMICALS AND DRUGS
Enzymes and Coenzymes [D08]Enzymes and Coenzymes -
CHEMICALS AND DRUGS
Enzymes and Coenzymes [D08]Enzymes and Coenzymes -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins
|
Anistreplase
- Conceito preferido
Iminase
- Mais específico
BRL-26921
- Mais específico
Eminase
- Mais específico
Identificador do conceito |
M0024829 |
Nota de escopo | An acylated inactive complex of streptokinase and human lysine-plasminogen. After injection, the acyl group is slowly hydrolyzed, producing an activator that converts plasminogen to plasmin, thereby initiating fibrinolysis. Its half-life is about 90 minutes compared to 5 minutes for TPA; (TISSUE PLASMINOGEN ACTIVATOR); 16 minutes for UROKINASE-TYPE PLASMINOGEN ACTIVATOR and 23 minutes for STREPTOKINASE. If treatment is initiated within 3 hours of onset of symptoms for acute myocardial infarction, the drug preserves myocardial tissue and left ventricular function and increases coronary artery patency. Bleeding complications are similar to other thrombolytic agents. |
Termo preferido | Anistreplase |
Termo(s) alternativo(s) |
APSAC Anisoylated Plasminogen-Streptokinase Activator Complex |
Identificador do conceito |
M0433989 |
Termo preferido | Iminase |
Identificador do conceito |
M0333009 |
Termo preferido | BRL-26921 |
Termo(s) alternativo(s) |
BRL 26921 BRL26921 |
Identificador do conceito |
M0024830 |
Termo preferido | Eminase |
Queremos a sua opinião sobre o novo sitio web do DeCS/MeSH
Convidamos-lhe a responder a uma pesquisa que não levará mais que 3 minutos
Ir para pesquisa